Reply to Harrington et al

Clin Infect Dis. 2015 Aug 15;61(4):667-8. doi: 10.1093/cid/civ403. Epub 2015 May 22.

Authors

Sreetha Sidharthan¹, Anita Kohli¹, Shyam Kottilil²

Affiliations

¹ Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda.
² Institute of Human Virology, University of Maryland, Baltimore Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Drug Monitoring / methods*
Female
Hepacivirus / drug effects*
Hepatitis C / drug therapy*
Humans
Male
Viral Load / drug effects*

Substances

Antiviral Agents